This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Antengene Discovery Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yulong He: Innovator in PRMT5 Inhibiting Compounds
Introduction
Yulong He is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit PRMT5. His work is crucial in the ongoing fight against various diseases, including cancers.
Latest Patents
Yulong He holds a patent for "PRMT5 inhibiting compounds and uses thereof." This patent provides novel PRMT5 and/or MTA-cooperative PRMT5 inhibiting compounds, or pharmaceutically acceptable salts thereof. The application also details pharmaceutical compositions that include these compounds as an active ingredient, highlighting their potential use in treating diseases or disorders, including cancers. He has 1 patent to his name.
Career Highlights
Yulong He is currently associated with Antengene Discovery Limited, where he continues to innovate and develop new therapeutic solutions. His expertise in the field has positioned him as a key player in pharmaceutical research and development.
Collaborations
Yulong He has worked alongside notable colleagues such as Ming Zhang and Ya Kong. Their collaborative efforts contribute to the advancement of research in the pharmaceutical industry.
Conclusion
Yulong He is a dedicated inventor whose work in PRMT5 inhibiting compounds holds promise for the treatment of serious diseases. His contributions to pharmaceutical sciences are invaluable and continue to pave the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile